0.00Open0.00Pre Close0 Volume0 Open Interest32.50Strike Price0.00Turnover2199.27%IV-39.10%PremiumJul 19, 2024Expiry Date20.87Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9884Delta0.0026Gamma--Leverage Ratio-4.3273Theta0.0000Rho0.00Eff Leverage0.0002Vega
Molson Coors Beverage Stock Discussion
$EOG Resources(EOG.US)$ $FS KKR Capital(FSK.US)$ $Molson Coors Beverage(TAP.US)$ $CF Industries Holdings(CF.US)$ $The Mosaic(MOS.US)$ $YIELDMAX NVDA OPTION INCOME STRATEGY ETF(NVDY.US)$
$Waters(WAT.US)$ $Molson Coors Beverage(TAP.US)$ $Anheuser-Busch Inbev(BUD.US)$ $Coca-Cola(KO.US)$ $Xylem(XYL.US)$ $ThaiBev(Y92.SG)$ $Lennar Corp(LEN.US)$ $D.R. Horton(DHI.US)$ $PepsiCo(PEP.US)$ $3M(MMM.US)$ $Applied Materials(AMAT.US)$ $Netflix(NFLX.US)$ $Advanced Micro Devices(AMD.US)$ $Lululemon Athletica(LULU.US)$
Morgan Stanley anticipated annual global sales for weight-loss drugs could reach $77 billion by 2030, higher than its previous $54 billion forecast. $Novo-Nordisk A/S(NVO.US)$ and $Eli Lilly and Co(LLY.US)$ will spli...
No comment yet